Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Bakkt (BKKT-WT) Research & Development (2021 - 2026)

Bakkt has reported Research & Development over the past 6 years, most recently at $1.8 million for Q1 2026.

  • For Q1 2026, Research & Development fell 8.64% year-over-year to $1.8 million; the TTM value through Mar 2026 reached $8.7 million, down 12.49%, while the annual FY2025 figure was $7.3 million, 22.89% down from the prior year.
  • Research & Development for Q1 2026 was $1.8 million at Bakkt, down from $1.8 million in the prior quarter.
  • Over five years, Research & Development peaked at $5.9 million in Q1 2024 and troughed at -$3.2 million in Q4 2023.
  • A 5-year average of $3.2 million and a median of $3.7 million in 2024 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: crashed 171.47% in 2023 and later skyrocketed 168.69% in 2024.
  • Year by year, Research & Development stood at $4.4 million in 2022, then plummeted by 171.47% to -$3.2 million in 2023, then soared by 168.69% to $2.2 million in 2024, then dropped by 17.24% to $1.8 million in 2025, then fell by 0.5% to $1.8 million in 2026.
  • Business Quant data shows Research & Development for BKKT-WT at $1.8 million in Q1 2026, $1.8 million in Q4 2025, and $2.2 million in Q3 2025.